Forte A, Rinaldi B, Berrino L, Rossi F, Galderisi U and Cipollaro M: Novel potential targets for prevention of arterial restenosis: Insights from the pre-clinical research. Clin Sci (Lond). 127:615–634. 2014. View Article : Google Scholar

Dzau VJ, Braun-Dullaeus RC and Sedding DG: Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med. 8:1249–1256. 2002. View Article : Google Scholar

Osherov AB, Gotha L, Cheema AN, Qiang B and Strauss BH: Proteins mediating collagen biosynthesis and accumulation in arterial repair: Novel targets for anti-restenosis therapy. Cardiovasc Res. 91:16–26. 2011. View Article : Google Scholar

Kumar A, Kumar Singh U and Chaudhary A: Honokiol analogs: A novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med Chem. 5:809–829. 2013. View Article : Google Scholar

Pan J, Lee Y, Wang Y and You M: Honokiol targets mitochondria to halt cancer progression and metastasis. Mol Nutr Food Res. 60:1383–1395. 2016. View Article : Google Scholar

Hu H, Zhang XX, Wang YY and Chen SZ: Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol Sin. 26:1063–1068. 2005. View Article : Google Scholar

Zhang GS, Wang RJ, Zhang HN, Zhang GP, Luo MS and Luo JD: Effects of chronic treatment with honokiol in spontaneously hypertensive rats. Biol Pharm Bull. 33:427–431. 2010. View Article : Google Scholar

Fetalvero KM, Martin KA and Hwa J: Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins Other Lipid Mediat. 82:109–118. 2007. View Article : Google Scholar

Patel SD, Waltham M, Wadoodi A, Burnand KG and Smith A: The role of endothelial cells and their progenitors in intimal hyperplasia. Ther Adv Cardiovasc Dis. 4:129–141. 2010. View Article : Google Scholar

Lee B, Kim CH and Moon SK: Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett. 580:5177–5184. 2006. View Article : Google Scholar

Fan S, Li X, Lin J, Chen S, Shan J and Qi G: Honokiol inhibits tumor necrosis factor-α-stimulated rat aortic smooth muscle cell proliferation via caspase- and mitochondrial-dependent apoptosis. Inflammation. 37:17–26. 2014. View Article : Google Scholar

Seedial SM, Ghosh S, Saunders RS, Suwanabol PA, Shi X, Liu B and Kent KC: Local drug delivery to prevent restenosis. J Vasc Surg. 57:1403–1414. 2013. View Article : Google Scholar :

Chaudhary MA, Guo LW, Shi X, Chen G, Gong S, Liu B and Kent KC: Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery. J Control Release. 233:174–180. 2016. View Article : Google Scholar :

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

Chen W, Chu Y, Zhu D, Yan C, Liu J, Ji K and Gao P: Perivascular gene transfer of dominant-negative N19RhoA attenuates neointimal formation via inhibition of TGF-beta1-Smad2 signaling in rats after carotid artery balloon injury. Biochem Biophys Res Commun. 389:217–223. 2009. View Article : Google Scholar

Suwanabol PA, Kent KC and Liu B: TGF-β and restenosis revisited: A Smad link. J Surg Res. 167:287–297. 2011. View Article : Google Scholar :

Lu P, Wang S, Cai W and Sheng J: TGF-beta 1/Smad3 expression and its effects on carotid intimal hyperplasia. Front Biosci (Elite Ed). 4:2022–2028. 2012. View Article : Google Scholar

Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, Little PJ and Osman N: Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation. Cell Signal. 25:2017–2024. 2013. View Article : Google Scholar

Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S and Pauletto P: Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Circ Res. 89:1111–1121. 2001. View Article : Google Scholar

Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC and Virmani R: Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation. 115:1051–1058. 2007. View Article : Google Scholar

Chiang CK, Sheu ML, Lin YW, Wu CT, Yang CC, Chen MW, Hung KY, Wu KD and Liu SH: Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro. Br J Pharmacol. 163:586–597. 2011. View Article : Google Scholar :

Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 85:1–31. 2005. View Article : Google Scholar

Azevedo A, Prado AF, Antonio RC, Issa JP and Gerlach RF: Matrix metalloproteinases are involved in cardiovascular diseases. Basic Clin Pharmacol Toxicol. 115:301–314. 2014. View Article : Google Scholar

Jacob MP: Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother. 57:195–202. 2003. View Article : Google Scholar

Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL and Aggarwal BB: Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res. 4:621–633. 2006. View Article : Google Scholar

Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, et al: Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Oncotarget. 6:37335–37348. 2015. View Article : Google Scholar :

Kim KR, Park KK, Chun KS and Chung WY: Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of pro-inflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage. J Pharmacol Sci. 114:69–78. 2010. View Article : Google Scholar

Chen YJ, Tsai KS, Chan DC, Lan KC, Chen CF, Yang RS and Liu SH: Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. J Orthop Res. 32:573–580. 2014. View Article : Google Scholar

Zhang YF, Zhou SZ, Cheng XY, Yi B, Shan SZ, Wang J and Li QF: Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-β/Smad2/3 signalling pathway. Br J Dermatol. 174:120–130. 2016. View Article : Google Scholar